未登录.png)
分享.png)
收藏Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
Dirschka, T.; Radny, P.; Dominicus, R.; Mensing, H.; Bruening, H.; Jenne, L.; Karl, L.; Sebastian, M.; Oster-Schmidt, C.; Kloevekorn, W.; Reinhold, U.; Tanner, M.; Groene, D.; Deichmann, M.; Simon, M.; Huebinger, F.; Hofbauer, G.; Kraehn-Senftleben, G.; Borrosch, F.; Reich, K.; Berking, C.; Wolf, P.; Lehmann, P.; Moers-Carpi, M.; Hoenigsmann, H.; Wernicke-Panten, K.; Hahn, S.; Pabst, G.; Voss, D.; Foguet, M.; Schmitz, B.; Luebbert, H.; Szeimies, R. -M. 分享 收藏 Actinic KeratosesStockfleth, Eggert; Terhorst, Dorothea; Hauschild, Axel; Zouboulis, Christos C.; Schlaeger, Martin; Oster-Schmidt, Claus; Diepgen, Thomas; Garbe, Claus; Gollnick, Harald; Korting, Christian; Merk, Hans; Sterry, Wolfram; Kerl, Helmut; Berking, Carola 分享 收藏 Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboDirschka, T.; Radny, P.; Dominicus, R.; Mensing, H.; Bruening, H.; Jenne, L.; Karl, L.; Sebastian, M.; Oster-Schmidt, C.; Kloevekorn, W.; Reinhold, U.; Tanner, M.; Groene, D.; Deichmann, M.; Simon, M.; Huebinger, F.; Hofbauer, G.; Kraehn-Senftleben, G.; Borrosch, F.; Reich, K.; Berking, C.; Wolf, P.; Lehmann, P.; Moers-Carpi, M.; Hoenigsmann, H.; Wernicke-Panten, K.; Helwig, C.; Foguet, M.; Schmitz, B.; Luebbert, H.; Szeimies, R. -M. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
